Search
for
Sort by
Research 181–210 of 1000+
- Retinoids - new uses and new synthetic agents
- Dermatological drugs and topical agents
- COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
- Cosmetic dermatologic surgery
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
- Dermatologic Surgery in Aging Skin
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- JOURNAL SCAN
- [Dermatologic therapy unit anti-androgens].
- 18β‐Glycyrrhetinic acid: its core biological properties and dermatological applications
- Fullerene nanoparticle in dermatological and cosmetic applications
- Update dermatologic laser therapy
- A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
- Dermatological Illnesses of Immigrant Poultry-Processing Workers in North Carolina
- Dermatological practice and psychiatry
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Single-handed vampire facial: Combining microneedling with platelet-rich plasma for single-hand use
- The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years
- Body dysmorphic concerns, social adaptation, and motivation for psychotherapeutic support in dermatological outpatients
- 14 Dermatological drugs, topical agents, and cosmetics
- Tacrolimus ointment: summarizing two decades of experience in off-label use. Use in rosacea, seborrheic dermatitis, papulosquamous dermatoses, lupus erythematosus, eczematous dermatoses, alopecia, and other diseases
- ROSMARINUS OFFICINALIS: HAIR, SKIN AND OTHER POSSIBLE THERAPEUTIC ACTIVITIES
- Dermatological care of gender‐diverse patients in Australia
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- Dermatological Issues Among Individuals Receiving Palliative Care - A Review
- Dermatological Manifestations of COVID-19: A Brief Review
- DERMATOLOGICAL ADVERSE EFFECTS OF CHEMOTHERAPEUTIC AGENTS: EXPERIENCE FROM A TERTIARY CENTRE
- Spironolactone use and the risk of breast cancer
- SÍNDROME DOS OVÁRIOS POLICÍSTICOS E MANIFESTAÇÕES DERMATOLÓGICAS: DO DIAGNÓSTICO À TERAPÊUTICA ESTÉTICA
- Dermatological aspects of primary psychiatric disorders